Ying-Cheng Wang
王英正
MD, PhD
Professor and Director, Division of Pulmonary and Critical Care Medicine胸腔暨重症医学科教授兼主任
👥Biography 个人简介
Leading Taiwanese expert in EGFR- and ALK-mutant NSCLC. Has conducted pivotal Taiwanese and Asia-Pacific clinical trials of EGFR TKIs (gefitinib, erlotinib, afatinib, osimertinib) and ALK inhibitors, and led research characterizing the genomic landscape of NSCLC in East Asian populations.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
EGFR/ALK NSCLC in Asian Populations
Led Taiwanese clinical trials characterizing EGFR mutation prevalence and EGFR TKI efficacy in East Asian NSCLC patients, and investigated mechanisms of resistance to first- and second-generation EGFR TKIs in Asian populations.
Representative Works 代表性著作
EGFR mutations in patients with non-small cell lung cancer
New England Journal of Medicine (2004)
Among the landmark papers first characterizing EGFR-activating mutations and their association with TKI response in NSCLC, including data from Asian patient populations.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 王英正 的研究动态
Follow Ying-Cheng Wang's research updates
留下邮箱，当我们发布与 Ying-Cheng Wang（China Medical University Hospital）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment